Sign inJoin waitlistJoin the waitlist

Jennifer Chakrabarty

Professor of Medicine · University of Oklahoma College of Medicine

Credentials: · · ·

History

University of Oklahoma College of Medicine
Present
University of Oklahoma College of Medicine
Present
University of Oklahoma College of Medicine
Present

Hematology/Oncology OU College of Medicine
2002–2005
Internal Medicine OU College of Medicine
1999–2002
University of Oklahoma College of Medicine
1995–1999
University of Oklahoma
1991–1995

Research

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Journal of Clinical Oncology · 2018 · 2,915 citations
Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients…
Journal of Clinical Oncology · 2017 · 292 citations
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events
Journal for ImmunoTherapy of Cancer · 2020 · 240 citations

GS
George Selby
11 papers
Mohamad Cherry
8 papers
Kirsten Williams
7 papers
Alexandra Arteaga
5 papers
Mohamad Khawandanah
5 papers
Robert Epstein
5 papers
Christopher Kanakry
4 papers
Jeffery Auletta
4 papers
JG
Joshua Glover
4 papers · 4 as a fellow
Manu Pandey
4 papers
WK
William Kern
4 papers
Adam Cuker
3 papers

Grants

Imaging and Blood Biomarkers to Predict Graft Failure After HSCT
National Heart, Lung, and Blood Institute · R01
PI · $2.9M · Emory University
2019–2026
Non-Invasive Assessment of Graft vs Host Disease Using Optoacoustic Imaging
National Cancer Institute · R21
Contact PI · $362.7K · University of Oklahoma Hlth Sciences Ctr
2023–2024

Clinical trials

Pilot Imaging Study of Leukemia
Principal investigator · Recruiting · Phase 1
University of Oklahoma
2023–2029
Impact of Palliative Transfusions on Quality of Life in Patients With Blood Cancers on Hospice
Principal investigator · Completed
University of Oklahoma
2020–2023
Assessment of Suspected Intracranial Malignancy Using 3'-Deoxy-3'18 F-flourothymidine PET
Principal investigator · Terminated
University of Oklahoma
2008–2010
REVEAL Biomarkers of Engraftment After Alternative Donor HSCT
Site PI · Recruiting · Phase 1
University of Oklahoma
2020–2027